Jersey Shore University Medical Center Now Providing Patients with Phase I Clinical Trial Innovative Therapies

What You Need To Know

• Experts from John Theurer Cancer Center have now established a satellite phase I clinical trial program at Jersey Shore University Medical Center. 

“The program offers novel, first-in-human treatment options and provides new hope for patients with solid tumors who have exhausted other available therapies,” said Oncologist Martin Gutierrez, M.D., co-chief, Thoracic Oncology Division, director of the Drug Discovery and Phase I Unit, John Theurer Cancer Center. “This includes immunotherapy, developmental therapeutics, targeted therapies and cell therapies.” 

• The site offers comprehensive medical and surgical oncology/hematology consultative services by national experts for all types and stages of cancer and serious blood disorders. This includes full infusion services, genomics analysis, and more all provided in accordance with John Theurer quality standards and protocols.

Learn More

To learn more about Phase I clinical trials at Jersey Shore University Medical Center, call 551-996-5497.  For more information, visit www.hackensackmeridianhealth.org/en/services/cancer-care.